Mechanical support in acute and chronic heart failure.
Heart failure (HF) is the leading cause of hospital admissions in the United States in people over the age of 65 years. Major advancements in the medical therapy of HF, combined with automatic implantable cardioverter-defibrillators and cardiac resynchronization therapy, have substantially reduced the mortality and morbidity of chronic HF, but mortality remains high, and the availability of donor hearts for transplantation is limited. Thus, there has been and continues to be a need for alternative therapies to support the failing heart. The development of mechanical pumps designed to assist or replace cardiac function started three decades ago with the National Heart, Lung, and Blood Institute's request for proposals to develop an artificial heart. Significant progress has been made, with ventricular assist devices evolving from bulky extracorporeal devices to internalized miniaturized devices. Improvements in durability, thrombogenicity, ease of implantation, and patient selection have allowed expanding indications for these devices.
Brieke
Andreas
A
University of Colorado at Denver and Health Sciences Center, Division of Cardiology, 12631 East 17th Avenue, B130, Aurora, CO 80045, USA. andreas.brieke@uchsc.edu
Cleveland
Joseph
J
Lindenfeld
JoAnn
J
D000208:Acute Disease; D002908:Chronic Disease; D004867:Equipment Design; D004868:Equipment Failure; D006333:Heart Failure / Q000628:therapy*; D006353:Heart-Assist Devices / Q000009:adverse effects; D006801:Humans; D013923:Thromboembolism; D016896:Treatment Outcome